Randomized controlled trial to evaluate clinical efficacy of once- or twice-daily skincare with emollient for prevention of atopic dermatitis exacerbatio
Not Applicable
Recruiting
- Conditions
- Atopic dermatitis
- Registration Number
- JPRN-UMIN000005158
- Lead Sponsor
- ational Center for Child Health and Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are taking oral steroids and/or oral immunosuppressive drug
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The rates of patients with free of recurrence during 28 days of intervention. 2. No symptom days after entry of this intervention.
- Secondary Outcome Measures
Name Time Method 1. QOL of a caregiver (a parent) 2. Scoring atopic dermatitis (SCORAD) 3. Incidence of skin infection